Marzetti Company stock price target raised to $200 from $185 at Benchmark

Marzetti Company (MZTI) reported robust fourth-quarter fiscal 2025 results, with revenues and adjusted EPS meeting consensus, while adjusted gross margin of 22.9% and adjusted EBITDA of $61 million surpassed expectations. Retail sales growth of 5.4% also significantly exceeded management's forecast. In response, Benchmark raised its price target to $200 with a Buy rating, though DA Davidson maintained a Neutral stance. Despite these positive financial outcomes, MZTI's stock declined in premarket trading, indicating cautious investor sentiment.

Analysis

Marzetti Company (MZTI) delivered a strong fourth-quarter fiscal 2025 performance, with key metrics meeting or exceeding consensus expectations. The company reported adjusted revenues of $458 million, excluding a temporary supply contract, and an adjusted EPS of $1.33, which was in line with estimates. Profitability showed significant improvement, as the adjusted gross margin expanded 130 basis points year-over-year to 22.9%, and adjusted EBITDA of $61 million surpassed the $60 million forecast. A key driver was the retail segment, where sales growth of 5.4% substantially outpaced management's 2% guidance. Analyst reactions are mixed; Benchmark upgraded its price target to $200, maintaining a 'Buy' rating and citing a valuation based on a 16x forward EBITDA multiple on FY27 estimates. In contrast, DA Davidson reiterated a 'Neutral' rating with a $193 target. Despite the solid operational results, the stock declined in premarket trading, indicating that cautious investor sentiment, potentially driven by broader market trends, is currently outweighing the company-specific positive news.

Key Decisions for Investors

• Investors may view the premarket stock decline as a buying opportunity, given the strong underlying performance, including significant retail sales outperformance and margin expansion.
• Monitor whether the 5.4% retail sales growth momentum can be sustained, as this was a primary driver of the quarterly beat and will be critical for justifying further upside.
• Note the divergence in analyst ratings, with Benchmark's 'Buy' suggesting value while DA Davidson's 'Neutral' implies a more balanced risk/reward, warranting caution until the market digests the results.